Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update [Yahoo! Finance]
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
Gain Therapeutics Highlights GT-02287 Biomarker Signals, Eyes Phase 2 Start in Q3 at Roth Conference [Yahoo! Finance]
Gain Therapeutics to Present at the 38th Annual ROTH Conference [Yahoo! Finance]
Gain Therapeutics to Present at the 38th Annual ROTH Conference